Dapirolizumab pegol, a novel CD40L inhibitor, is superior to placebo for achieving low disease activity and remission in systemic lupus erythematosus, according to data presented at the EULAR 2025 ...

Burnout among health care workers has decreased since the COVID-19 public health emergency ended, but has not returned to ...

Myopia progression does not rebound after stopping long-term wear of SightGlass Vision’s myopia-controlling Diffusion Optics ...

I was fascinated to learn a few years ago that AI could reliably determine the sex of an individual when analyzing a fundus ...

Patients with chronic kidney disease who had hypertension and diabetes and received insulin therapy showed a 35% lower risk ...

Despite increasing clinical awareness, more than half of U.S. adults do not know about the association between alcohol ...

Despite a Supreme Court ruling against race-conscious admissions, medical school applicants can still recognize their diverse ...

A single, oral dose of rimegepant offered superior relief as soon as 2 hours post-dose compared with placebo in patients with ...

Although Jennifer Namazy, MD, FAAAAI, was first a mentee of Sandra Christiansen, MD, they are now lifelong friends who are ...

Results published in Journal of Arthroplasty showed patients discharged to a skilled nursing facility after total knee ...

Hypercortisolism is tied to multiple cardio-renal-metabolic disorders, making cortisol level screening an important part of ...

In this video, Jeremy S. Abramson, MD, discusses 2-year results from the phase 3 STARGLO trial, which were presented at ASCO ...